Related Experiment Videos
Osteoporosis in chronic liver disease: a case-control study
Ghizlane Wariaghli1, Aziza Mounach, Lahsen Achemlal
1Rheumatology and Physical Rehabilitation Department, Military Hospital Mohammed V, PO Box: 1018, Rabat, Morocco. wariaghli@yahoo.com
Osteoporosis is a common complication in chronic liver disease (CLD) patients, occurring at twice the rate seen in the general population. Female sex, cholestasis, and lower body weight/height are key risk factors for developing this bone condition in CLD.
Area of Science:
- Hepatology
- Endocrinology
- Orthopedics
Background:
- Osteoporosis is an emerging complication in patients suffering from chronic liver disease (CLD).
- Understanding the prevalence and specific risk factors for osteoporosis in CLD is crucial for patient management.
Purpose of the Study:
- To determine the prevalence of osteoporosis in patients with CLD (primary biliary cirrhosis, chronic viral hepatitis B or C).
- To identify risk factors associated with osteoporosis in CLD patients compared to age- and sex-matched controls.
Main Methods:
- Dual-energy X-ray absorptiometry (DXA) was used to assess bone mineral density at the lumbar spine and total hip.
- Vertebral fractures were identified using densitometric morphometry (vertebral fracture assessment).
- Serum markers of bone turnover (parathyroid hormone, osteocalcin, C-telopeptides) were analyzed.
Main Results:
- The prevalence of osteoporosis in CLD patients was 45.3%, significantly higher than in controls (19.6%).
- Risk factors identified include female sex, cholestasis, lower weight, and lower height; age, menopausal status, and disease stage were not significant.
- Vertebral fractures were present in 5.3% of CLD patients.
Conclusions:
- Osteoporosis is a significant complication of chronic liver disease.
- Cholestasis, female sex, and lower body weight/height are identified as key risk factors for osteoporosis in the CLD population.
Related Concept Videos
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Chronic Pancreatitis II: Pathophysiology
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Chronic Pancreatitis I: Introduction